Last edition
News about "neurological disorder "
Takeda's Oveporexton NDA Accepted by US FDA with Priority Review for Narcolepsy Type 1
FDA grants Priority Review to Takeda’s investigational orexin receptor agonist oveporexton (TAK-861) for narcolepsy type 1, with a PDUFA decision expected in Q3 this year.
Neurological Disorder | 11/02/2026 | By News Bureau | 138
Alkem Foundation Organises Walkathons to Raise Awareness about Alzheimer's Disease
Alkem Foundation collaborated with non-profit organization, HelpAge India for these walkathons, which were conducted at Girgaon Chowpatty in Mumbai, Deer Park in New Delhi, Chetla Central Park in Kolkata, Anna Nagar Tower Park in Chennai and National College Ground in Bengaluru.
Neurological Disorder | 21/09/2024 | By Aishwarya | 709
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy